[ad_1] RT @ViralKansaraPhD: Excited to share the abstract on ocular #pharmacokinetics. Suprachoroidal delivery of this small molecule complement i… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @ThomasCiullaMD: Just published…Lean Six Sigma concepts can reduce waste and enhance patient care: Evolution of Primary Scleral Bucklin… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] Our research was featured recently in Ophthalmology Times…. #retina #eyes #ophthalmology #ophthalmologist #optometry https://t.co/afuUqaz25c [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @RetinalPhys: Suprachoroidal Gene Transfer: A noninvasive approach to transduce photoreceptors and retinal pigment epithelium. By Peter… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] Just presented at ARVO: Pharmacokinetics and Ocular Tolerability of Suprachoroidal CLS-AX (axitinib injectable suspension) in rabbits | IOVS | ARVO Journals https://t.co/h81HLca3O8 #retina #eyes #ophthalmology #ophthalmologist #optometry https://t.co/cLfEdT0Jgx [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RNA therapy has generated great interest in the broader medical community, after approvals for devastating systemic disorders such as spinal muscular atrophy and Duchenne muscular dystrophy … https://t.co/IASbx4uC1n [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] Our paper reporting the first successful phase 3 clinical trial for Suprachoroidal Delivery came out in this month’s issue of Ophthalmology. https://t.co/vsNrOm4F8v [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.